ANDAORALTABLET
Approved
May 2019
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
6
Clinical Trials (5)
Rosuvastatin Calcium Bioequivalence Study - Fast
Started Feb 2013
60 enrolled
Hypercholesterolaemia
Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) and Rosuvastatin Calcium
Started Dec 2008
90 enrolled
Healthy
Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg
Started Nov 2008
90 enrolled
Healthy
Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin Calcium
Started May 2008
64 enrolled
Adverse EventsPharmacokinetic
A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia
Started Apr 2007
760 enrolled
HypercholesterolemiaDyslipidemia